ACSL1 and central nervous system cancer: In a recent study on glioma, lower expression of ACSL1 was also found to reverse the accelerated cellular metabolism and tumor growth induced by PRADX (a novel lncRNA ENST00000449248.1 identified by Xu et al., 2022) overexpression in vivo and in vitro.